Physician Education for Fistula Treatment Act

The bill, introduced on 2026-05-22 by Rep. DeLauro (D-CT), is at the earliest legislative stage — referred to committee with no further action. It authorizes assistance for training and retaining OB/GYNs and urogynecology specialists in least developed countries to address obstetric fistula. No dollar amounts are specified in the bill text. There is no procurement or direct spending mechanism that would channel funds to US-based public companies. The policy area is International Affairs, and the bill's focus is on foreign aid capacity-building. As an authorization-only bill with no appropriation language, any eventual spending would require a separate appropriations bill. The impact on US healthcare markets is negligible — the affected patient population and medical providers are entirely outside the US. No publicly traded US companies are named or directly affected by the training programs described. Legislative momentum is low: single sponsor, no cosponsors, no companion bill, no committee markup, no amendments. This is a typical early-stage international development authorization bill with no near-term market relevance.